Sonoma Pharmaceuticals, INC. (SNOA) — 10-Q Filings

All 10-Q filings from Sonoma Pharmaceuticals, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Sonoma Pharma's Revenue Jumps, But Cash Drains Amidst Mounting Losses — Nov 4, 2025 Risk: high
Sonoma Pharmaceuticals, Inc. (SNOA) reported a net loss of $534,000 for the three months ended September 30, 2025, an improvement from a net loss of $610,000 in
Sonoma Pharma's Q1 Revenue Dips 17%, Net Loss Widens — Aug 7, 2025 Risk: high
Sonoma Pharmaceuticals, Inc. reported a significant decline in revenue for the three months ended June 30, 2025, dropping to $3.5 million from $4.2 million in t
Sonoma Pharmaceuticals Files Q3 2025 10-Q — Feb 5, 2025 Risk: medium
Sonoma Pharmaceuticals, Inc. filed its 10-Q for the period ending December 31, 2024. The company, formerly known as Oculus Innovative Sciences, Inc., is in the
Sonoma Pharmaceuticals Files Q2 FY25 10-Q — Nov 7, 2024 Risk: medium
Sonoma Pharmaceuticals, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly Oculus Innovative Sciences, Inc., reported financial
Sonoma Pharmaceuticals Files Q1 2025 10-Q — Aug 8, 2024 Risk: low
Sonoma Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the first quarter of their fiscal year 2025. The company prev
Sonoma Pharmaceuticals, Inc. Files 10-Q for Period Ending December 31, 2023 — Feb 8, 2024 Risk:
Sonoma Pharmaceuticals, Inc. (SNOA) filed a Quarterly Report (10-Q) with the SEC on February 8, 2024. Sonoma Pharmaceuticals, Inc. filed a 10-Q for the period e

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX